Benitec Biopharma's total assets for Q3 2026 were AU$187.00M, a decrease of -1.93% from the previous quarter. BNTC total liabilities were AU$3.67M for the fiscal quarter, a 10.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.